Research

Analysing DNA to provide accurate diagnoses and help predict the outcome of retinoblastoma (Rb)

Researchers are investigating eye fluid samples from retinoblastoma patients to make the test as reliable and cost efficient as possible so it can be introduced into clinical service.

Therapeutic potential of new tumour suppressor, PRELP, in retinoblastoma

The aim is to examine the effect of the secreted protein PRELP on the progression of retinoblastoma.

Further investigation into intra-ocular fluid as a liquid biopsy in retinoblastoma